Cytori Cell Research Institute, Inc.(JP:3750)
Â¥800.00+23.00 (+2.96%)
JP:3750
Cytori Cell Research Institute, Inc. financials statements
Â¥800.00
At close:+23.00 (+2.96%)
Want to see JP:3750 full AI Analyst Report?
Cytori Cell Research Institute, Inc. (3750) Ratios
1 Followers
Cytori Cell Research Institute, Inc. Ratios
JP:3750's free cash flow for Q1 2026 was ¥0.00. For the 2026 fiscal year, JP:3750's free cash flow was increased by ¥0.00 and operating cash flow was ¥0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.55 | 1.05 | 2.66 | 1.18 | 3.04 |
| Quick Ratio | 1.25 | 0.96 | 2.47 | 1.08 | 1.39 |
| Cash Ratio | 0.56 | 0.52 | 1.94 | 0.96 | 0.86 |
| Solvency Ratio | -1.15 | -0.72 | 0.13 | -0.06 | 0.02 |
| Operating Cash Flow Ratio | -3.46 | -2.01 | -2.15 | -0.03 | -0.19 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -2.79 | -9.24 | -0.04 | -0.26 |
| Net Current Asset Value | ¥ 4.48M | ¥ -2.39B | ¥ -1.59B | ¥ -10.05B | ¥ -9.26B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.75 | 0.42 | 0.60 | 0.58 |
| Debt-to-Equity Ratio | 0.00 | 4.20 | 0.89 | 3.21 | 2.50 |
| Debt-to-Capital Ratio | 0.00 | 0.81 | 0.47 | 0.76 | 0.71 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.78 | 0.46 | 0.74 | 0.70 |
| Financial Leverage Ratio | 16.71 | 5.61 | 2.08 | 5.31 | 4.31 |
| Debt Service Coverage Ratio | -48.94 | -1.71 | 1.96 | -0.58 | 0.42 |
| Interest Coverage Ratio | -49.03 | -9.84 | -5.02 | -6.15 | -4.96 |
| Debt to Market Cap | 0.00 | 0.37 | 0.29 | 0.84 | 0.91 |
| Interest Debt Per Share | 2.07 | 305.80 | 294.07 | 967.27 | 1060.23 |
| Net Debt to EBITDA | 0.14 | -3.16 | -2.38 | -10.47 | 24.12 |
| Profitability Margins | |||||
| Gross Profit Margin | 19.35% | -45.46% | 82.82% | 59.17% | 64.33% |
| EBIT Margin | -1777.23% | -660.28% | -54.95% | -48.34% | 2.09% |
| EBITDA Margin | -1775.87% | -619.71% | -38.65% | -32.89% | 26.12% |
| Operating Profit Margin | -1777.23% | -660.28% | -49.52% | -37.04% | -34.62% |
| Pretax Profit Margin | -780.29% | -1761.64% | -64.81% | -54.37% | -4.89% |
| Net Profit Margin | -778.43% | -1751.24% | 8.85% | -49.42% | -5.81% |
| Continuous Operations Profit Margin | -778.43% | -1751.41% | 8.90% | -49.41% | -5.77% |
| Net Income Per EBT | 99.76% | 99.41% | -13.66% | 90.90% | 118.82% |
| EBT Per EBIT | 43.90% | 266.80% | 130.86% | 146.79% | 14.13% |
| Return on Assets (ROA) | -107.84% | -60.50% | 2.38% | -7.52% | -0.49% |
| Return on Equity (ROE) | -1802.06% | -339.41% | 4.95% | -39.96% | -2.09% |
| Return on Capital Employed (ROCE) | -641.14% | -26.49% | -14.63% | -6.15% | -3.08% |
| Return on Invested Capital (ROIC) | -639.62% | -23.59% | 1.96% | -5.22% | -2.94% |
| Return on Tangible Assets | -107.84% | -60.53% | 2.38% | -7.91% | -0.51% |
| Earnings Yield | -5.46% | -29.89% | 1.64% | -10.48% | -0.76% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.91 | 53.43 | 26.75 | 18.96 | 11.38 |
| Payables Turnover | 24.95 | 0.00 | -17.95 | -39.74 | 0.00 |
| Inventory Turnover | 0.62 | 3.97 | 2.59 | 7.54 | 0.29 |
| Fixed Asset Turnover | 0.00 | 0.04 | 0.37 | 0.18 | 0.11 |
| Asset Turnover | 0.14 | 0.03 | 0.27 | 0.15 | 0.08 |
| Working Capital Turnover Ratio | 0.68 | 0.27 | 2.82 | 1.91 | 0.35 |
| Cash Conversion Cycle | 975.52 | 98.77 | 174.99 | 76.88 | 1293.47 |
| Days of Sales Outstanding | 400.66 | 6.83 | 13.64 | 19.26 | 32.07 |
| Days of Inventory Outstanding | 589.49 | 91.94 | 141.01 | 48.44 | 1261.40 |
| Days of Payables Outstanding | 14.63 | 0.00 | -20.33 | -9.18 | 0.00 |
| Operating Cycle | 990.15 | 98.77 | 154.65 | 67.69 | 1293.47 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -87.90 | -110.55 | -129.05 | -4.43 | -21.27 |
| Free Cash Flow Per Share | -87.90 | -111.46 | -130.87 | -22.18 | -41.66 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | -122.07 | -70.88 | -0.25 | -1.04 |
| Capital Expenditure Coverage Ratio | 0.00 | -122.07 | -70.88 | -0.25 | -1.04 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.37 | -0.47 | -0.00 | -0.02 |
| Operating Cash Flow to Sales Ratio | -15.39 | -8.08 | -0.74 | -0.02 | -0.14 |
| Free Cash Flow Yield | -10.80% | -13.90% | -13.83% | -1.96% | -3.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -18.31 | -3.35 | 61.14 | -9.54 | -131.82 |
| Price-to-Sales (P/S) Ratio | 142.53 | 58.59 | 5.41 | 4.72 | 7.66 |
| Price-to-Book (P/B) Ratio | 329.97 | 11.36 | 3.03 | 3.81 | 2.76 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -9.26 | -7.20 | -7.23 | -51.08 | -27.82 |
| Price-to-Operating Cash Flow Ratio | -9.26 | -7.25 | -7.33 | -255.99 | -54.50 |
| Price-to-Earnings Growth (PEG) Ratio | 0.22 | 0.00 | -0.54 | -0.01 | 1.44 |
| Enterprise Value Multiple | -7.89 | -12.61 | -16.38 | -24.81 | 53.46 |
| Enterprise Value | 7.14B | 9.55B | 9.88B | 17.50B | 18.65B |
| EV to EBITDA | -7.89 | -12.61 | -16.38 | -24.81 | 53.46 |
| EV to Sales | 140.07 | 78.17 | 6.33 | 8.16 | 13.96 |
| EV to Free Cash Flow | -9.10 | -9.60 | -8.46 | -88.37 | -50.70 |
| EV to Operating Cash Flow | -9.10 | -9.68 | -8.57 | -442.84 | -99.32 |
| Tangible Book Value Per Share | 2.47 | 70.40 | 310.73 | 220.40 | 336.81 |
| Shareholders’ Equity Per Share | 2.47 | 70.62 | 312.58 | 297.10 | 420.47 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.01 | 1.14 | 0.09 | -0.18 |
| Revenue Per Share | 5.71 | 13.69 | 174.77 | 240.21 | 151.26 |
| Net Income Per Share | -44.46 | -239.70 | 15.47 | -118.71 | -8.79 |
| Tax Burden | 1.00 | 0.99 | -0.14 | 0.91 | 1.19 |
| Interest Burden | 0.44 | 2.67 | 1.18 | 1.12 | -2.35 |
| Research & Development to Revenue | 3.01 | 1.66 | 0.23 | 0.07 | 0.02 |
| SG&A to Revenue | 14.96 | 4.49 | 0.12 | 0.07 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 1.98 | 0.46 | -8.35 | 0.04 | 2.42 |
Currency in JPY
